The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...